Summit Trail Advisors, LLC Dexcom Inc Transaction History

Summit Trail Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $20,517 - $26,123	-186 Reduced 5.83%	3,002 $340,000
Q1 2024 Apr 23, 2024	BUY	$114.22 - $140.1 $85,322 - $104,654	747 Added 30.6%	3,188 $442,000
Q4 2023 Feb 06, 2024	SELL	$75.49 - $124.16 $34,800 - $57,237	-461 Reduced 15.89%	2,441 $302,000
Q3 2023 Oct 30, 2023	SELL	$86.06 - $137.93 $154,563 - $247,722	-1,796 Reduced 38.23%	2,902 $270,000
Q2 2023 Jul 25, 2023	BUY	$112.47 - $130.98 $528,384 - $615,344	4,698 New	4,698 $603,000
Q1 2018 May 21, 2018	BUY	$13.06 - $18.54 $198,263 - $281,455	15,181 Added 8075.0%	15,369 $15,000
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $2,090 - $2,891	188	188 $11,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.